The novel treatment of this peptide represents a significant breakthrough in the care of type 2 diabetes. Distinct from existing drugs, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatide-peptide622405.luwebs.com/42973298/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment